FDA Approved: IBUPROFEN — Supplemental Application (Major Pharmaceuticals)

View source ↗

Summary

The FDA approved Major Pharmaceuticals' ibuprofen supplemental application, finalizing regulatory changes for this product under an ANDA process.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dysmenorrhea
• Juvenile Idiopathic Arthritis
• Osteoarthritis
• Rheumatoid Arthritis

Drugs mentioned

• Ibuprofen (IBUPROFEN)

Snippet

SUPPL AP for IBUPROFEN (IBUPROFEN)